BridgeMD
New treatment option for Atrioventricular Nodal Reentry Tachycardia
Official title Localization of Anatomical Structures Involved in Nodal Tachycardias by High Density Mapping.
ClinicalTrials.gov ID: NCT05296954
What this study is testing
- What it's testing
- The aim of the present work is to analyze the capacity of high resolution mapping systems to determine the precise location of the AV node and peri-nodal slow-conducting pathways, using standard recording parameters, but also off-line additional filter changes and additional techniques (conduction velocities, isochrones and dV/dt). The investigative team plan a prospective monocentric study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Group 1: Patients without heart disease presenting with reciprocal tachycardia by intra-nodal reentry.
- Group 2: Control people, without nodal tachycardia, without heart disease, and admitted for ablation of atrial fibrillation or ventricular...
You likely can't join if
- Presence of underlying structural heart disease or history of atrial ablation or atrial tachycardia
- Minor or protected patient
- Patient under guardianship, curatorship or safeguard of justice
The study team makes the final eligibility decision.
Where it's taking place
- Toulouse, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toulouse, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.